Skip to main content
TipRanks
Go Ultimate75% OFF

Samuel R. Nussbaum Insider Profile

4 Followers

Samuel R. Nussbaum, Director at Biora Therapeutics, holds 47.52K shares in Biora Therapeutics (Ticker: BIORQ), holds ― shares in Coherus Biosciences (Ticker: CHRS), holds 97.69K shares in Motus Gi Holdings (Ticker: MOTS).

Samuel R. Nussbaum's Trading History

BIORQ
Biora Therapeutics
Jun 16, 2021DirectorUninformative Buy――
MOTS
Motus Gi Holdings
Feb 19, 2021DirectorUninformative Buy―$976.89
ELV
Elevance Health
May 21, 2015EVP & Chief Medical OfficerUninformative Sell1.65M$47.68M
CHRS
Coherus Biosciences
―Director――

You May Also Like

Samuel R. Nussbaum insider profile FAQ

What is the percentage of profitable transactions made by Samuel R. Nussbaum?
The percentage of profitable transactions made by Samuel R. Nussbaum is 25%.
What is the average return per transaction made by Samuel R. Nussbaum?
The average return per transaction made by Samuel R. Nussbaum is -17.50%.
What stocks does Samuel R. Nussbaum hold?
Samuel R. Nussbaum holds: BIORQ, CHRS, ELV, MOTS stocks.
What was Samuel R. Nussbaum's most profitable transaction?
Samuel R. Nussbaum’s most profitable transaction was an Informative Buy of MOTS stock on February 21, 2018. The return on the trade was 1.80%.
What is Samuel R. Nussbaum's role in Biora Therapeutics?
Samuel R. Nussbaum's role in Biora Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.